Pharmaceuticals, namely immunotherapeutic agents for the treatment of infectious diseases including viral, bacterial and parasitic infections such as malaria, inflammatory and autoimmune diseases including arthritis, psoriasis and vasculitis and reperfusion injury, cardiovascular diseases including atherosclerosis and stroke, neurodegenerative disorders such as Alzheimer's disease and metabolic diseases such as diabetes; pharmaceuticals, namely polypeptides for the treatment of the aforesaid ...